MedVector

08/19/2024

Last day to invest in my company before we begin contracting with BIG Pharma! (Only $500 minimum investment.)

A clinical trial could save your life…

08/19/2024

Last chance to invest in MedVector before we start contracting with big pharma! (Min investment only $500.)

A clinical trial could save your life…

07/18/2024

If you’re curious about my company, I’m hosting a webinar today at 12:00 PST.

12/01/2023

This is true! In fact, we’ve raised $3.5m with a lot of help from our Yum Yum Videos!

09/20/2021

New explainer video about how MedVector creates access to patients.

MedVector's 2nd explainer video for unlocking patient access.

07/12/2021

Check out our new explainer video! The focus of this video is to showcase how MedVector creates access to patients behind non-research physicians who otherwise don't refer to clinical trials.

MedVector's 2nd explainer video for unlocking patient access.

06/19/2021

Happy to announce Craig Lipset joining the MedVector team!

Craig Lipset

05/28/2021

Please take a moment to honor those who have fought for our freedoms on this Memorial Day weekend. Have a good holiday.

04/15/2021

We welcome our new Strategic Advisor John Neal, chairman of network who will help us bring CROs and Pharma beyond clinical trial sites with our new technology platform. "The clinical trials industry is ready for MedVector’s innovative technology, which connects patients at local providers with investigators at existing clinical trial sites," says John.

MedVector announces that it has appointed John Neal, founder and chairman of PCRS Network, as strategic advisor, pharma relations and clinical protocol.

03/23/2021

Read more about MedVector and how we are expanding subject enrollment beyond clinical trial sites in Outsourcing-Pharma in partnership with CROs and sponsors. #

The company’s Prime-Control Technology is designed to help study teams expand their subject enrollment beyond the reach of their clinical trial sites.